The global Zidovudine API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Zidovudine(CAS锛�30516-87-1) is a nucleoside analogue and reverse transcriptase inhibitor used in combination with other agents in the therapy and prophylaxis of the human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Zidovudine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Zidovudine API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Zidovudine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Zidovudine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Zidovudine API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Zidovudine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Zidovudine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan, Hetero Drugs, HEC Pharm, ZHEJIANG LANGHUA PHARMACEUTICAL, Shanghai Shyndec Pharmaceutical, Shanghai Desano Bio-Pharmaceutical, Cipla, Nortec Quimica, Globe Quimica Ltda, Guangzhou Tosun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Zidovudine API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Above 98 %
Above 99 %
Market segment by Application
Injection
Tablets
Capsules
Others
Major players covered
Mylan
Hetero Drugs
HEC Pharm
ZHEJIANG LANGHUA PHARMACEUTICAL
Shanghai Shyndec Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
Cipla
Nortec Quimica
Globe Quimica Ltda
Guangzhou Tosun Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Zidovudine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Zidovudine API, with price, sales quantity, revenue, and global market share of Zidovudine API from 2020 to 2025.
Chapter 3, the Zidovudine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Zidovudine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Zidovudine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Zidovudine API.
Chapter 14 and 15, to describe Zidovudine API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Zidovudine API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Above 98 %
1.3.3 Above 99 %
1.4 Market Analysis by Application
1.4.1 Overview: Global Zidovudine API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Injection
1.4.3 Tablets
1.4.4 Capsules
1.4.5 Others
1.5 Global Zidovudine API Market Size & Forecast
1.5.1 Global Zidovudine API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Zidovudine API Sales Quantity (2020-2031)
1.5.3 Global Zidovudine API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Mylan
2.1.1 Mylan Details
2.1.2 Mylan Major Business
2.1.3 Mylan Zidovudine API Product and Services
2.1.4 Mylan Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Mylan Recent Developments/Updates
2.2 Hetero Drugs
2.2.1 Hetero Drugs Details
2.2.2 Hetero Drugs Major Business
2.2.3 Hetero Drugs Zidovudine API Product and Services
2.2.4 Hetero Drugs Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Hetero Drugs Recent Developments/Updates
2.3 HEC Pharm
2.3.1 HEC Pharm Details
2.3.2 HEC Pharm Major Business
2.3.3 HEC Pharm Zidovudine API Product and Services
2.3.4 HEC Pharm Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 HEC Pharm Recent Developments/Updates
2.4 ZHEJIANG LANGHUA PHARMACEUTICAL
2.4.1 ZHEJIANG LANGHUA PHARMACEUTICAL Details
2.4.2 ZHEJIANG LANGHUA PHARMACEUTICAL Major Business
2.4.3 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Product and Services
2.4.4 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 ZHEJIANG LANGHUA PHARMACEUTICAL Recent Developments/Updates
2.5 Shanghai Shyndec Pharmaceutical
2.5.1 Shanghai Shyndec Pharmaceutical Details
2.5.2 Shanghai Shyndec Pharmaceutical Major Business
2.5.3 Shanghai Shyndec Pharmaceutical Zidovudine API Product and Services
2.5.4 Shanghai Shyndec Pharmaceutical Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
2.6 Shanghai Desano Bio-Pharmaceutical
2.6.1 Shanghai Desano Bio-Pharmaceutical Details
2.6.2 Shanghai Desano Bio-Pharmaceutical Major Business
2.6.3 Shanghai Desano Bio-Pharmaceutical Zidovudine API Product and Services
2.6.4 Shanghai Desano Bio-Pharmaceutical Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Shanghai Desano Bio-Pharmaceutical Recent Developments/Updates
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Zidovudine API Product and Services
2.7.4 Cipla Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cipla Recent Developments/Updates
2.8 Nortec Quimica
2.8.1 Nortec Quimica Details
2.8.2 Nortec Quimica Major Business
2.8.3 Nortec Quimica Zidovudine API Product and Services
2.8.4 Nortec Quimica Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Nortec Quimica Recent Developments/Updates
2.9 Globe Quimica Ltda
2.9.1 Globe Quimica Ltda Details
2.9.2 Globe Quimica Ltda Major Business
2.9.3 Globe Quimica Ltda Zidovudine API Product and Services
2.9.4 Globe Quimica Ltda Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Globe Quimica Ltda Recent Developments/Updates
2.10 Guangzhou Tosun Pharmaceutical
2.10.1 Guangzhou Tosun Pharmaceutical Details
2.10.2 Guangzhou Tosun Pharmaceutical Major Business
2.10.3 Guangzhou Tosun Pharmaceutical Zidovudine API Product and Services
2.10.4 Guangzhou Tosun Pharmaceutical Zidovudine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Zidovudine API by Manufacturer
3.1 Global Zidovudine API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Zidovudine API Revenue by Manufacturer (2020-2025)
3.3 Global Zidovudine API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Zidovudine API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Zidovudine API Manufacturer Market Share in 2024
3.4.3 Top 6 Zidovudine API Manufacturer Market Share in 2024
3.5 Zidovudine API Market: Overall Company Footprint Analysis
3.5.1 Zidovudine API Market: Region Footprint
3.5.2 Zidovudine API Market: Company Product Type Footprint
3.5.3 Zidovudine API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Zidovudine API Market Size by Region
4.1.1 Global Zidovudine API Sales Quantity by Region (2020-2031)
4.1.2 Global Zidovudine API Consumption Value by Region (2020-2031)
4.1.3 Global Zidovudine API Average Price by Region (2020-2031)
4.2 North America Zidovudine API Consumption Value (2020-2031)
4.3 Europe Zidovudine API Consumption Value (2020-2031)
4.4 Asia-Pacific Zidovudine API Consumption Value (2020-2031)
4.5 South America Zidovudine API Consumption Value (2020-2031)
4.6 Middle East & Africa Zidovudine API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Zidovudine API Sales Quantity by Type (2020-2031)
5.2 Global Zidovudine API Consumption Value by Type (2020-2031)
5.3 Global Zidovudine API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Zidovudine API Sales Quantity by Application (2020-2031)
6.2 Global Zidovudine API Consumption Value by Application (2020-2031)
6.3 Global Zidovudine API Average Price by Application (2020-2031)
7 North America
7.1 North America Zidovudine API Sales Quantity by Type (2020-2031)
7.2 North America Zidovudine API Sales Quantity by Application (2020-2031)
7.3 North America Zidovudine API Market Size by Country
7.3.1 North America Zidovudine API Sales Quantity by Country (2020-2031)
7.3.2 North America Zidovudine API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Zidovudine API Sales Quantity by Type (2020-2031)
8.2 Europe Zidovudine API Sales Quantity by Application (2020-2031)
8.3 Europe Zidovudine API Market Size by Country
8.3.1 Europe Zidovudine API Sales Quantity by Country (2020-2031)
8.3.2 Europe Zidovudine API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Zidovudine API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Zidovudine API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Zidovudine API Market Size by Region
9.3.1 Asia-Pacific Zidovudine API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Zidovudine API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Zidovudine API Sales Quantity by Type (2020-2031)
10.2 South America Zidovudine API Sales Quantity by Application (2020-2031)
10.3 South America Zidovudine API Market Size by Country
10.3.1 South America Zidovudine API Sales Quantity by Country (2020-2031)
10.3.2 South America Zidovudine API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Zidovudine API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Zidovudine API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Zidovudine API Market Size by Country
11.3.1 Middle East & Africa Zidovudine API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Zidovudine API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Zidovudine API Market Drivers
12.2 Zidovudine API Market Restraints
12.3 Zidovudine API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Zidovudine API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Zidovudine API
13.3 Zidovudine API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Zidovudine API Typical Distributors
14.3 Zidovudine API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Mylan
Hetero Drugs
HEC Pharm
ZHEJIANG LANGHUA PHARMACEUTICAL
Shanghai Shyndec Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
Cipla
Nortec Quimica
Globe Quimica Ltda
Guangzhou Tosun Pharmaceutical
听
听
*If Applicable.
